These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18155722)

  • 1. Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences.
    Montagne M; Naud JF; Lavigne P
    J Mol Biol; 2008 Feb; 376(1):141-52. PubMed ID: 18155722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
    Sauvé S; Tremblay L; Lavigne P
    J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
    Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
    Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
    Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
    J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
    Lebel R; McDuff FO; Lavigne P; Grandbois M
    Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
    J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the elucidation of the structural determinants responsible for the molecular recognition between Mad1 and Max.
    Montagne M; Naud JF; McDuff FO; Lavigne P
    Biochemistry; 2005 Sep; 44(38):12860-9. PubMed ID: 16171401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
    J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
    Sauvé S; Naud JF; Lavigne P
    J Mol Biol; 2007 Jan; 365(4):1163-75. PubMed ID: 17109882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
    McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
    J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
    Davis LJ; Halazonetis TD
    Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of Max: role of basic, helix-loop-helix/leucine zipper domains in DNA binding, dimerization and regulation of Myc-mediated transcriptional activation.
    Reddy CD; Dasgupta P; Saikumar P; Dudek H; Rauscher FJ; Reddy EP
    Oncogene; 1992 Oct; 7(10):2085-92. PubMed ID: 1408152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA binding of Myc/Max/Mad network complexes to oligonucleotides containing two E box elements: c-Myc/Max heterodimers do not bind DNA cooperatively.
    Vervoorts J; Lüscher B
    Biol Chem; 1999 Sep; 380(9):1121-6. PubMed ID: 10543451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and properties of a Myc derivative that efficiently homodimerizes.
    Soucek L; Helmer-Citterich M; Sacco A; Jucker R; Cesareni G; Nasi S
    Oncogene; 1998 Nov; 17(19):2463-72. PubMed ID: 9824157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity.
    D'Agnano I; Valentini A; Gatti G; Chersi A; Felsani A
    J Cell Physiol; 2007 Jan; 210(1):72-80. PubMed ID: 16998799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
    Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA binding by N- and L-Myc proteins.
    Ma A; Moroy T; Collum R; Weintraub H; Alt FW; Blackwell TK
    Oncogene; 1993 Apr; 8(4):1093-8. PubMed ID: 8455937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
    Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
    PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.